Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-22-000197
Filing Date
2022-02-11
Accepted
2022-02-11 16:20:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss792104_sc13g.htm SC 13G 41259
  Complete submission text file 0000947871-22-000197.txt   42768
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Subject) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-93441 | Film No.: 22621324
SIC: 2834 Pharmaceutical Preparations